Growth Metrics

Supernus Pharmaceuticals (SUPN) Change in Acquisitions & Divestments (2016 - 2025)

Supernus Pharmaceuticals (SUPN) has disclosed Change in Acquisitions & Divestments for 15 consecutive years, with $39.3 million as the latest value for Q4 2025.

  • Quarterly Change in Acquisitions & Divestments fell 70.43% to $39.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $774.5 million through Dec 2025, up 55.25% year-over-year, with the annual reading at $774.5 million for FY2025, 55.25% up from the prior year.
  • Change in Acquisitions & Divestments for Q4 2025 was $39.3 million at Supernus Pharmaceuticals, down from $468.6 million in the prior quarter.
  • The five-year high for Change in Acquisitions & Divestments was $468.6 million in Q3 2025, with the low at $17.6 million in Q4 2022.
  • Average Change in Acquisitions & Divestments over 5 years is $118.3 million, with a median of $72.1 million recorded in 2021.
  • The sharpest move saw Change in Acquisitions & Divestments tumbled 95.36% in 2022, then skyrocketed 729.88% in 2023.
  • Over 5 years, Change in Acquisitions & Divestments stood at $378.0 million in 2021, then crashed by 95.36% to $17.6 million in 2022, then surged by 102.87% to $35.6 million in 2023, then soared by 273.5% to $133.0 million in 2024, then plummeted by 70.43% to $39.3 million in 2025.
  • According to Business Quant data, Change in Acquisitions & Divestments over the past three periods came in at $39.3 million, $468.6 million, and $110.4 million for Q4 2025, Q3 2025, and Q2 2025 respectively.